Tokyo, Japan

Kunio Ezawa


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1989-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kunio Ezawa: Innovator in Complement Component Research

Introduction

Kunio Ezawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of complement component research, holding a total of 2 patents. His work focuses on innovative methods involving substance-conjugated complement components, which have important applications in immunology.

Latest Patents

Ezawa's latest patents include a test method involving substance-conjugated complement component C1q. This invention provides a substance-conjugated complement component C1q, where a substance such as signal-emitting substances or cell function-regulating substances is conjugated via a sulfur atom to at least one site of the component. The site is specifically chosen to avoid involvement in binding immunoglobulins. This marker-labelled complement component C1q is utilized for measuring a complement-binding antibody, an antigen, a neutralizing antibody, or a substance produced internally or at the surface of a cell or microorganism by measuring the marker.

Career Highlights

Throughout his career, Kunio Ezawa has worked with various companies, including Calpis Food Industry. His innovative approaches have led to advancements in the understanding and application of complement components in biological research.

Collaborations

Ezawa has collaborated with notable individuals in his field, including Fumiaki Taguchi and Isamu Mitsui. These partnerships have contributed to the development of his patents and the advancement of research in complement components.

Conclusion

Kunio Ezawa's contributions to the field of complement component research highlight his innovative spirit and dedication to scientific advancement. His patents reflect a commitment to improving methods for measuring important biological substances.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…